European Medicines Agency Recommends Six New Drugs for Approval
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued positive opinions for six new medicines, including treatments for metastatic pancreatic cancer, type 2 diabetes, and achondroplasia, alongside two biosimilars. These recommendations are a crucial step towards making new therapeutic options available to patients across Europe.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.
Open NewsSnap.ai